Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

11%

1 trials in Phase 3/4

Results Transparency

50%

3 of 6 completed trials have results

Key Signals

2 recruiting3 with results

Enrollment Performance

Analytics

N/A

4(66.7%)

Phase 2

1(16.7%)

Phase 3

1(16.7%)

6Total

N/A(4)

Phase 2(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT03936361Phase 3Recruiting

Statins In Intracerbral Hemorrhage

Role: collaborator

NCT05205356Recruiting

VIGOR: Virtual Genome Center for Infant Health

Role: collaborator

NCT05927480Not ApplicableCompleted

Audio Distraction for Traction Pin Placement

Role: collaborator

NCT01614106Not ApplicableCompleted

Project RETAIN: Providing Integrated Care for HIV-Infected Crack Cocaine Users

Role: collaborator

NCT03275350Phase 2Completed

Comparing Treatments for HIV-Infected Opioid Users in an Integrated Care Effectiveness Study (CHOICES) Scale-Up

Role: collaborator

NCT02641158Not ApplicableCompleted

Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.

Role: collaborator

NCT02915406Unknown

cliniMACs HUD for T Cell Depletion

Role: collaborator

NCT01612169Not ApplicableCompleted

Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users

Role: collaborator

NCT01561469Completed

Evaluation of Patients With Methicillin-Resistant Staphylococcus Aureus Hospital-Acquired Pneumonia Treated With Linezolid or Vancomycin

Role: collaborator

All 9 trials loaded